US OptionsDetailed Quotes
MRK240726C126000
- 1.00
- +0.63+170.27%
15min DelayClose Jul 24 16:00 ET
1.03High0.52Low
0.54Open0.37Pre Close961 Volume1.18K Open Interest126.00Strike Price90.78KTurnover27.51%IV0.86%PremiumJul 26, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry1.00Extrinsic Value100Contract SizeAmericanOptions Type0.4952Delta0.1703Gamma138.37Leverage Ratio-0.3514Theta0.0028Rho68.52Eff Leverage0.0340Vega
Merck & Co Stock Discussion
After shooting, Bitcoin price briefly surpassed $63,000. $Trump Media & Technology(DJT.US)$ surged over 70% in Mond...
Reports suggest Biden acknowledged the importance of his upcoming appearances, though the White House denies this claim. His stumbling debate performance and questions about his mental acuity have caused panic within the Democratic Party, leading to speculation about a...
$Merck & Co(MRK.US)$ already has an active partnership with $Janux Therapeutics(JANX.US)$ for two TRACtr targets, and CEO Davis has evinced a preference for acquisition of $SPDR S&P Biotech ETF(XBI.US)$ in which $Merck & Co(MRK.US)$ already has a seat at the table.
$Merck & Co(MRK.US)$ acquisition of $HARP earlier this year (for a song) shows their interest in the T Cell engag...
📌 This week’s PDUFAs:
$Merck & Co(MRK.US)$ : 🤔
⇨ Patritumab deruxtecan
‣ Non-small cell lung carcinoma
‣ PDUFA date: 6/26/24 (BLA)
$Verona Pharma(VRNA.US)$ : 🤔
⇨ Ensifentrine (Nebulized)
‣ Chronic obstructive pulmonary disease
‣ PDUFA date: 6/26/24 (NDA)
$Genmab(GMAB.US)$ : 🤔
⇨ EPKINLY® (Epcoritamab)
‣ Follicular lymphoma
‣ PDUFA date: 6/28/24 (sBLA)
🗓️ Last week’s PDUFAs:
$Merck & Co(MRK.US)$ : Approved 6/17 🎉
⇨ CAPVAXIVE (V116)
‣ Pneumo...
$Harmony Biosciences(HRMY.US)$ : WAKIX (pitolisant)
$Bristol-Myers Squibb(BMY.US)$ : KRAZATI (Adagrasib) + Cetuximab
$argenx SE(ARGX.US)$ : VYVGART Hytrulo (Efgartigimod)
$Merck & Co(MRK.US)$ : Patritumab deruxtecan
$Verona Pharma(VRNA.US)$ : Ensifentrine (Nebulized)
$Rocket Pharmaceuticals(RCKT.US)$ : KRESLADI (Marnetegragene autotemcel)
FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine)
⇨ for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults 🫁
» CAPVAXIVE (V116) protects against most strains causing illness in adults over 50. 🛡️
» Effective in people who've never had a pneumococcal vaccine or already have one as demonstrated in Ph3 trials.
Gapping up
$Chegg(CHGG.US)$ stock saw an impressive 18.01% increase after the education technology company announced a significant workforce reduction, cutting 23% of its global staff as a part of an extensive restructuring initiative.
$Merck & Co(MRK.US)$ shares experienced a 1.11% uptick following the U.S. Food and Drug Administration's approval of the pharmaceutical giant's advanced vaccine designed to protect a...
No comment yet